- Gold Supporters -
A trusted partner in reproductive genomics, Illumina offers a portfolio of solutions across the reproductive health continuum. Our integrated reproductive and genetic health portfolio includes preimplantation genetic screening (PGS), preimplantation genetic diagnosis (PGD) technology, and noninvasive prenatal testing (NIPT). Learn more about our portfolio by visiting www.illumina.com/RGH.
- Silver Supporters -
CooperGenomics brings together legacy companies Reprogenetics, Recombine, and Genesis Genetics under the CooperSurgical family of companies. Through carrier screening, PGD, PGS, NIPT, and beyond, we are committed to advancing the field of reproductive genetics, improving outcomes, and empowering families.
75 Corporate Drive
Trumbull, CT 06611
Reprogenetics: (973) 436-5000
Genesis Genetics: (313) 579-9650
IBSA Genetics, IBSA Institut Biochimique SA
Company Address: IBSA Institut Biochimique SAVia del Piano, P.O. Box 266, 6915 Pambio-Noranco, Lugano, Switzerland
Company Tel: +41 58 360 10 00
Company Fax: +41 58 360 16 47
General Email Address: firstname.lastname@example.org
Website: www.chromoscreen.com; www.ibsa-international.com
IBSA Genetics description
IBSA Genetics is a new division of IBSA Institut Biochimique SA, devoted to the development of technologically advanced solutions for genetic testing in cytogenetics and IVF. IBSA Genetics combines its unique scientific and technological expertise with the collaboration with some of the world’s leading IVF centers. IBSA Genetics developed Chromoscreen®, a novel microarray-based test for Preimplantation Genetic Screening to assess the chromosome arrangement in embryos before implantation in IVF. It includes everything is required to investigate aneuploidies in polar bodies, blastomeres and trophectoderm cells.IBSA Genetics also developed Chromoscreen Software® , a bioinformatic tool for array analysis, samples management and patient tracking.
- Supporters -
ARCEDI Biotech ApS
ARCEDI Biotech ApS is a Danish biotech company that has developed a technology for the enrichment of rare circulating fetal cells from maternal blood for use in cell-based noninvasive prenatal diagnosis (cbNIPD). Currently the technology is being tested in a clinical setting with an expected launch of the test in the fall of 2017. More information about ARCEDI, its technology, and its peer-reviewed publications can be found at www.arcedi.com.
Main Office: Lysholt Alle 10. DK-7100, Vejle. Denmark
Aarhus Office: INCUBA. Palle-Juul Jensens Boulevard 82. DK-8200, Aarhus N. Denmark
Counsyl is a DNA testing and genetic counseling service committed to helping patients understand their DNA and how it can inform important health decisions. Whether it’s starting a family or evaluating risk for cancer, Counsyl's DNA tests provide patients with early awareness about genetic conditions, so they can live informed and prepare for the future. Counsyl has screened more than 750,000 patients and served more than 10,000 healthcare professionals. For more information, visit www.counsyl.com.
Roche Sequencing Solutions
Headquartered in Pleasanton, California, the Roche Sequencing Unit is focused on developing novel sequencing technologies and products to support innovation in clinical research applications. Our goal is to develop assays for sequencing, and refine sequencing techniques to advance sequencing technologies that will deliver truly differentiated clinical value.
- Exhibitors -
Quermed was founded in 1978, with a clear vocation to be an efficient and dynamic vehicle in the introduction of the latest medical technology in Spain. We are specialist in the field of Assisted Reproduction and Reproductive Genetic Diagnosis. Our reputation and the fact of being a reference in our sector, is due a great human team of professionals and to our client, who have trusted us throughout all these years.
LifeGlobal Group, EVOLVE (Leaders in Genetic Fertility Screening), FertiPro, CCD International.
SYNLAB Group is the leading medical diagnostics provider in Europe. Providing the leading level of service within the industry, SYNLAB is the partner of choice for healthcare professionals. SYNLAB’s services also encompass veterinary and environmental laboratory analysis. SYNLAB operates in more than 30 countries across 4 continents with over 17,000 employees.